Chandan Healthcare
Chandan Healthcare Share Price Chart
Chandan Healthcare last traded at ₹231.00 (2026-10-13). Over the past month the stock moved +13.7%, three months the stock moved -1.7%, year the stock moved +2.7%. Its closing range over 52 weeks is ₹191.05 – ₹334.15, with the latest close 30.9% below the high.
Closing prices up to 2026-10-13.
About Chandan Healthcare
Incorporated in September 2003, Chandan Healthcare Limited runs diagnostic centers in North India with pathology and radiology testing services.[1]
Business Profile[1] Chandan Healthcare Limited operates a diagnostic network in North India that offers pathology and radiology testing services. The company has a presence in Uttar Pradesh, Uttarakhand, and Jaipur (Rajasthan), with a strong network of labs, satellite centers, and collection points.
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Chandan Healthcare reported sales of ₹80.85 crore (+19.1%) and net profit of ₹7.92 crore (+27.9%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 80.85 | 19.58 | 24.22 | 7.92 | 3.07 |
| Mar 2026 | 75.58 | 11.48 | 15.19 | 4.94 | 2.00 |
| Dec 2025 | 65.01 | 11.84 | 18.21 | 4.54 | 1.86 |
| Sep 2025 | 67.90 | 14.15 | 20.84 | 7.80 | 3.19 |
| Jun 2025 | 67.90 | 13.87 | 20.43 | 6.19 | 2.37 |
| Mar 2025 | 62.65 | 10.24 | 16.34 | 6.02 | 2.46 |
| Dec 2024 | 54.64 | 8.89 | 16.27 | 4.20 | 2.10 |
| Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|
| Sales growth | +19.0% | +20.6% | +19.1% |
| Operating profit growth | +33.2% | +12.1% | +41.2% |
| Net profit growth | +8.1% | -17.9% | +27.9% |
| EPS growth | -11.4% | -18.7% | +29.5% |
| OPM % | 18.2% | 15.2% | 24.2% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Chandan Healthcare reported sales of ₹276.00 crore (+20.0%) and net profit of ₹27.00 crore (+12.5%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 276.00 | 53.00 | 19.00 | 27.00 | 11.07 |
| Mar 2025 | 230.00 | 41.00 | 18.00 | 24.00 | 9.07 |
| Mar 2024 | 177.00 | 26.00 | 15.00 | 16.00 | 8.14 |
| Mar 2023 | 137.00 | 9.00 | 7.00 | 3.00 | 1.68 |
| Mar 2022 | 120.00 | 2.00 | 2.00 | -1.00 | -0.56 |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales growth | +14.2% | +29.2% | +29.9% | +20.0% |
| Operating profit growth | +350.0% | +188.9% | +57.7% | +29.3% |
| Net profit growth | – | +433.3% | +50.0% | +12.5% |
| EPS growth | – | +384.5% | +11.4% | +22.1% |
| OPM % | 7.0% | 15.0% | 18.0% | 19.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Chandan Healthcare.
Get Free AI Stock Analysis FREE →Latest News
-
Top 2 stocks to buy or sell tomorrow: Laurus Labs, Indus Towers by Chandan Taparia - Check stop-loss, targets
-
Top 2 stocks to buy or sell tomorrow: Laurus Labs, Indus Towers by Chandan Taparia - Check stop-loss, targets
-
Top 2 stocks to buy or sell tomorrow: Laurus Labs, Indus Towers by Chandan Taparia - Check stop-loss, targets
-
‘Growth is improving, uncertainties are going down': Bajaj MF CIO Nimesh Chandan - BusinessLine
-
TVS Motors, Divi's Laboratories among top stock picks by Chandan Taparia - Business Standard
-
TVS Motors, Divi's Laboratories among top stock picks by Chandan Taparia - Business Standard
-
Chandan Healthcare reports Profit after tax of Rs 67.09 Mln, in the June 2026 quarter
-
Moneyview, Chandan Steel Get Sebi’s Approval To Float IPOs
-
SEBI Clears IPOs For Moneyview, Chandan Steel; Shivganga Withdraws - Whalesbook
-
Moneyview, Chandan Steel Get Sebi’s Approval To Float IPOs
Frequently Asked Questions
What is the share price of Chandan Healthcare today?
Chandan Healthcare shares were last quoted at ₹231.00 (-1.7% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Chandan Healthcare?
Chandan Healthcare has a price-to-earnings (P/E) ratio of 22.11 and a price-to-book (P/B) ratio of 3.39. The industry P/E is 101.02.
What is the 52-week high and low of Chandan Healthcare?
The 52-week high of Chandan Healthcare is ₹358.00 and the 52-week low is ₹185.40.
What is the market cap of Chandan Healthcare?
The market capitalisation of Chandan Healthcare is about ₹604.26 crore.
How did Chandan Healthcare perform in its latest quarterly results?
In the latest quarter (Jun 2026), Chandan Healthcare reported sales of ₹80.85 crore (+19.1%) and net profit of ₹7.92 crore (+27.9%), compared with the same quarter last year.
Is Chandan Healthcare a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Chandan Healthcare has a 3-year ROE of 22.00%, 3-year profit growth of 79.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Chandan Healthcare?
Promoters hold about 49.61% of Chandan Healthcare.
Which sector does Chandan Healthcare belong to?
Chandan Healthcare belongs to the Hospital & Healthcare Services sector.
Other Hospital & Healthcare Services stocks
- Apollo Hospitals Enterprises
- Max Healthcare Institute
- Manipal Health Enterprises
- Aster DM Quality Care
- Fortis Healthcare
- Global Health
- Narayana Hrudayalaya
- Krishna Institute of Medical Sciences
All Hospital & Healthcare Services stocks · Browse all stocks A–Z